Author:
Kätzel Dennis,Wolff Amy R.,Bygrave Alexei M.,Bannerman David M.
Funder
Deutsche Forschungsgemeinschaft
Wellcome Trust
Medical Research Council
Brain and Behavior Research Foundation
Else Kröner-Fresenius-Stiftung
Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg
Subject
Pharmacology (medical),Pharmacology
Reference228 articles.
1. A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia;Adams;BMC Psychiatry,2013
2. Pomaglumetad Methionil (LY2140023 Monohydrate) and Aripiprazole in Patients with Schizophrenia: A Phase 3, Multicenter, Double-Blind Comparison;Adams;Schizophr. Res. Treat,2014
3. Attenuation of Novelty-Induced Hyperactivity of Gria1-/- Mice by Cannabidiol and Hippocampal Inhibitory Chemogenetics;Aitta-aho;Front. Pharmacol.,2019
4. Different CA1 and CA3 Representations of Novel Routes in a Shortcut Situation;Alvernhe;J. Neurosci.,2008
5. Amphetamine psychosis: Behavioral and biochemical aspects;Angrist;J. Psychiatr. Res.,1974
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献